In the first half of 2025, the industry continued to face challenges from global geopolitical uncertainties and evolving domestic centralised procurement dynamics. However, supportive government ... Sep 01
Essex Bio-Technology Limited is pleased to announce that a Biologics License Application (“BLA”) for EB12-20145P (HLX04-O), a recombinant anti-VEGF humanized monoclonal ... Aug 16
The new strain found in and around Kent county... Dec 15
Restrictions are being imposed in parts of Europe in response to a rapid rise of COVID-19 infections ... Oct 16
Team of Experienced Healthcare Investors and Former Healthcare Executives Will Invest in Select Healthcare Companies to Seek to Accelerate Their Revenue Growth... Sep 13
-Advertisements-